Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Gustoeson Aug 21, 2020 9:30am
253 Views
Post# 31437628

UVGI-based viral deactivation

UVGI-based viral deactivation

If aynone remembers me,, you'll remember 5 yrs ago I used to ramble about the potentially imeasurable uses for Theralase tech evolutions in industrial and hospital sanitatzion primary focusing on CIP for equpment and machines against virus and bacterias. Imagine tld cv19 spray sanitizers with laser activation or hand driers that include laser...

Lidge appears to be looking in to some n95 stuff.

The current COVID-19 pandemic has severely stressed supplies of personal protective equipment (PPE), including N95 filtering facepiece respirators (N95 FFRs). In response, healthcare facilities worldwide are forced to extend the use or reuse of their N95 FFRs [4]. Few options can be adopted for N95 FFR reuse.

UVGI-based viral deactivation is an easy-to-use solution, and its efficacy on N95 respirators has been confirmed by several studies

UVGI is a reasonable approach for FFR decontamination to extend a respirator’s usable lifetime when supply chains are restricted during public health emergencies. Both the investment costs and environmental impact are low. Operator exposure to harmful UV radiation and ozone can be minimized by simple technical safety measures.

https://www.medrxiv.org/content/10.1101/2020.06.12.20129395v2.full.pdf

Bullboard Posts